CG Oncology Inc. (CGON) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

CG Oncology, Inc. Common stock

NASDAQ | CGON

18.74

USD

-3.5 (-15.74%)

AT CLOSE (AS OF Apr 3, 2025)

$1.7B

MARKET CAP

P/E Ratio

-1.41

EPS

$47

52 Week High

$19

52 Week Low

LIFE SCIENCES

Sector

CGON Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

CGON Technicals

Tags:

CGON Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$1.1M
Total Revenue	$1.1M
Cost Of Revenue	-
Costof Goods And Services Sold	-
Operating Income	-$115M
Selling General And Administrative	$34M
Research And Development	$82M
Operating Expenses	$116M
Investment Income Net	-
Net Interest Income	$27M
Interest Income	$27M
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$88M
Income Tax Expense	-
Interest And Debt Expense	-
Net Income From Continuing Operations	-$88M
Comprehensive Income Net Of Tax	-
Ebit	-
Ebitda	-$115M
Net Income	-$88M

Revenue & Profitability

Earnings Performance

CGON Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$755M
Total Current Assets	$754M
Cash And Cash Equivalents At Carrying Value	$257M
Cash And Short Term Investments	$257M
Inventory	-
Current Net Receivables	-
Total Non Current Assets	$587K
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	$485M
Other Current Assets	$11M
Other Non Current Assets	-
Total Liabilities	$21M
Total Current Liabilities	$21M
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$186K
Total Non Current Liabilities	$52K
Capital Lease Obligations	$238K
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$238K
Other Current Liabilities	$15M
Other Non Current Liabilities	-
Total Shareholder Equity	$733M
Treasury Stock	-
Retained Earnings	-$218M
Common Stock	$8K
Common Stock Shares Outstanding	$62M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$79M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$32K
Capital Expenditures	$234K
Change In Receivables	-
Change In Inventory	-
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$628M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$88M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$1.1M
Total Revenue	$1.1M
Cost Of Revenue	-
Costof Goods And Services Sold	-
Operating Income	-$115M
Selling General And Administrative	$34M
Research And Development	$82M
Operating Expenses	$116M
Investment Income Net	-
Net Interest Income	$27M
Interest Income	$27M
Interest Expense	-
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$88M
Income Tax Expense	-
Interest And Debt Expense	-
Net Income From Continuing Operations	-$88M
Comprehensive Income Net Of Tax	-
Ebit	-
Ebitda	-$115M
Net Income	-$88M

CGON Profile

CG Oncology, Inc. Common stock Profile

Sector: LIFE SCIENCES

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

None

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	776,312,724
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	242,972,129
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.81	2.86%	$399.65B	13,235,689
PG	$172.39	1.71%	$399.61B	9,393,270
ABBV	$201.64	-1.73%	$364.89B	7,580,327
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$73.92	2.35%	$225.70B	7,926,952

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$744.62K	310,904
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,499,750
OMQS	$0.06	62.16%	$1.50M	59,659

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
ICCT	$2.07	-56.14%	$9.78M	12,637,345